Detalhe da pesquisa
1.
The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.
Cell Microbiol
; 18(5): 617-31, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499863
2.
Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
Gut
; 65(2): 278-85, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25588406
3.
Covalent docking of large libraries for the discovery of chemical probes.
Nat Chem Biol
; 10(12): 1066-72, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344815
4.
Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype.
Gut
; 63(12): 1932-42, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658599
5.
Virulence factors and TEM-type ß-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain.
Antimicrob Agents Chemother
; 56(2): 1101-4, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22106220
6.
Erratum: Covalent docking of large libraries for the discovery of chemical probes.
Nat Chem Biol
; 11(3): 235, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25689339
7.
Noncovalent complexes of an inactive mutant of CTX-M-9 with the substrate piperacillin and the corresponding product.
Antimicrob Agents Chemother
; 55(12): 5660-5, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21930882
8.
In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli.
J Antimicrob Chemother
; 66(5): 1052-6, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21393211
9.
Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.
Sci Rep
; 9(1): 2175, 2019 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778122
10.
Analysis of structure-function relationships in the colibactin-maturating enzyme ClbP.
J Mol Biol
; 424(3-4): 203-14, 2012 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041299
11.
Evaluation of the efficiency of cefoxitin/cefepime combination against Enterobacteriaceae resistant to expanded-spectrum cephalosporins.
Int J Antimicrob Agents
; 45(1): 86-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25459401